Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Magdalena Kaniewska's publication output changed over time?
ScholarIQpublication output · 2004–2023
Output grew100% over the shown period — from 1 works in 2004 to 2 in 2023.
1
1
2
1
3
2
200420172020202120222023
What are the most-cited papers on Magdalena Kaniewska?
ScholarIQmost cited works
Telecommunications Infrastructure and Regional Economic Development: The Case of Poland
Andrzej Cieślik, Magdalena Kaniewska
S175672440. 2004105 Citations
Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
Martyna Szczubełek, Karolina Pomorska, Monika Korólczyk-Kowalczyk, Konrad Lewandowski, Magdalena Kaniewska, Grażyna Rydzewska
Nutrients. 202161 CitationsOPEN ACCESS
<i>Clostridioides difficile</i> infection in coronavirus disease 2019: an underestimated problem?
Konrad Lewandowski, Mariusz Rosołowski, Magdalena Kaniewska, Piotr Kucha, Anna Meler, Waldemar Wierzba, Grażyna Rydzewska
Polskie Archiwum Medycyny Wewnętrznej. 202060 CitationsOPEN ACCESS
The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
Magdalena Kaniewska, Andrzej Moniuszko, Grażyna Rydzewska
S90242659. 201727 CitationsOPEN ACCESS
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
Konrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, Mariusz Rosołowski, Grażyna Rydzewska
S90242659. 202227 CitationsOPEN ACCESS
Related on ScholarIQ
Ministry of Interior
Institution
Telecommunications Infrastructure and Regional Economic Development: The Case of Poland
Paper
Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
Paper
<i>Clostridioides difficile</i> infection in coronavirus disease 2019: an underestimated problem?
Paper
The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
Paper
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
Paper